Little is known about the effects of fetal ethanol exposure on lung development. Our aim was to determine the effects of repeated ethanol exposure during late gestation on fetal lung growth, maturation and inflammatory status. Pregnant ewes were chronically catheterized at 91 days of gestational age (DGA; term ~147d). From 95-133 DGA, ewes were given a one hour daily infusion of either 0.75 g ethanol/kg (n=9) or saline (n=8), with tissue collection at 134 DGA. Fetal lungs were examined for changes in tissue growth, structure, maturation, inflammation and oxidative stress. Between treatment groups there were no differences in lung weight, DNA and protein contents, percent proliferating and apoptotic cells, tissue and air-space fractions, alveolar number and mean linear intercept, septal thickness, type-II cell number and elastin content. Ethanol exposure caused a 75% increase in pulmonary collagen I α1 mRNA levels (p<0.05) and a significant increase in collagen deposition. Surfactant protein (SP)-A and SP-B mRNA levels were approximately one third of control levels following ethanol exposure (p<0.05). The mRNA levels of the pro-inflammatory cytokines interleukin (IL)-1β  and IL-8 were also lower (p<0.05) in ethanol-exposed fetuses compared to controls. Pulmonary malondialdehyde levels tended to be increased (p=0.07) in ethanol-exposed fetuses.
INTRODUCTION
Alcohol (ethanol) consumption during pregnancy remains a significant health problem in many countries, especially among some indigenous communities. Recent figures show that many women consume alcohol during pregnancy in developed countries; for example, it has been reported that 30% of American women (19) , 59% of Australian women (15) and 30-60% of European women (13, 17, 21, 26, 35, 38) drink alcohol at some stage during their pregnancy. Prenatal exposure to ethanol can result in the fetal alcohol syndrome (FAS) or fetal alcohol spectrum disorders (FASD), which are characterized by growth restriction, brain dysmorphology and dysfunction, in addition to craniofacial anomalies in the case of FAS (31, 34) . The effects of fetal ethanol exposure on brain development are well documented (48) ; however, less is known about the effects of prenatal ethanol exposure on other organs, in particular, the developing lungs.
To the best of our knowledge, there are no data on the effects of maternal alcohol consumption on fetal lung development in humans. However, alcohol consumption during pregnancy is known to increase the risk of low birthweight due to both preterm birth and intra-uterine growth restriction (IUGR) (18) . As low birthweight is associated with an increased incidence of respiratory distress in the neonate and maternal alcohol consumption increases the risk of neonatal infection (4, 22) , it is possible that prenatal ethanol exposure contributes to respiratory difficulties after birth.
It is well established that the lungs of adults can be affected by prolonged ethanol exposure. Alcoholic adults are known to have an increased risk of acute respiratory distress syndrome (ARDS) and pulmonary infections (1, 41) . Furthermore, adult lungs exposed to ethanol have been shown to have increased type-ll alveolar epithelial cell 4 apoptosis, as well as decreased surfactant synthesis and expression of proinflammatory cytokines (7, 16, (27) (28) (29) . If similar effects occurred in the fetus, functional development of the lungs could be impaired, contributing to respiratory distress after birth. Studies in rodents suggest inhibitory effects of prenatal ethanol exposure on lung growth (33, 50) , but there is little information on fetal lung maturation in a species in which lung development during pregnancy more closely resembles that in humans. In particular, there is little information on the effects of prenatal ethanol exposure on lung structure, pulmonary surfactant and the innate immune status of the lung before birth.
Our objective was to determine the effects of repeated ethanol exposure on the fetal lungs during the third-trimester equivalent, when structural and functional maturation of the lungs occurs. We have used sheep because the stages of lung development in the fetus are similar to those of humans, in which a large proportion of lung development, including the onset of alveolarization, occurs before birth (2, 9) . The repeated maternal alcohol dosage regimen, involving daily 1 hour ethanol infusions, was used to mimic human daily drinking of 3-4 standard drinks over one hour (40) . Alcohol readily passes in both directions across the sheep placenta and its clearance from the maternal-fetal unit is predominantly regulated by its metabolism to acetaldehyde in the maternal liver; this is comparable to the metabolism of ethanol in humans (6, 14) . In the present study, we examined the effects of repeated ethanol exposure during the third-trimester equivalent on fetal lung growth, parenchymal architecture and the surfactant system. As there is evidence that ethanol can affect pro-inflammatory cytokines in the lung (16, 27) , we also examined the expression of major pro-inflammatory cytokines.
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METHODS
Experimental procedure
Animal procedures were approved by the Monash University Animal Ethics Committee.
Pregnant Border-Leicester x Merino ewes underwent aseptic surgery at 91 days of gestational age (DGA; term ~147d). Anesthesia was induced by an intravenous injection of thiopental sodium (1g) and was maintained by inhalation of 1-2% halothane in Chemistry System. Fetal blood samples were also analyzed for arterial blood gases and glucose and lactate concentrations to determine the physiological state of the fetus.
The pregnant ewes and fetuses were humanely killed at 134 DGA by an intravenous overdose of sodium pentobarbital (130 mg/kg), which was administered to the ewe. The fetuses were weighed and the lungs removed and weighed. The left bronchus was then ligated and the left and right lungs separated. Small portions (avoiding major airways 6 and blood vessels) of the left lung were snap-frozen in liquid nitrogen and stored at -70°C for molecular analysis. The right lung was fixed via the trachea using 4% paraformaldehyde (in 0.1M phosphate buffer, pH 7.4) and at a distending pressure of 20 cmH 2 O. Sections were then processed and paraffin-embedded for light microscopy analyses.
DNA and protein assays
Pulmonary DNA and soluble protein concentrations were determined using an established fluorometric DNA assay and a standard colorimetric protein assay (Bio-Rad, Australia), respectively (30, 44) . DNA standards were prepared using salmon testes DNA (Sigma, Australia) diluted in sodium phosphate buffer (3M NaCl, 0.05M Na 2 HPO 4 , 0.05M NaH 2 PO 4 .2H 2 O, 0.002M EDTA, pH 7.4) to achieve concentrations of 100, 50, 25, 12.5, 6.25 and 0 µg/ml. Protein standards were prepared using bovine serum albumin (BSA; A-7888, Sigma, Australia) diluted in distilled water to achieve concentrations of 100, 50, 25, 12.5, 6.25 and 0 µg/ml.
Immunohistochemical analysis
Proliferating cells were identified by performing immunohistochemistry using an antibody against the Ki67 protein (1:100, 90 min incubation, mouse anti-human monoclonal antibody; DakoCytomation, Denmark). The Ki67 protein is expressed during all active phases of the cell cycle but is absent in resting cells and is therefore a suitable marker of cell proliferation (25) . 
Morphometric analysis
Paraffin-embedded sections of lung tissue were stained with hematoxylin and eosin.
Measurements were made by superimposing test grids over projected images of the lung. Measurements were made on coded slides by the same observer (GSM) who was blinded to the experimental groups. Tissue and air-space fractions, alveolar number, the mean linear intercept, or average distance between alveolar walls (Lm), and septal thickness were determined. The total number of alveoli (N A ) was determined using the 
Elastin and collagen analysis
Paraffin-embedded sections were stained for elastin using the Hart's resorcin-fuchsin stain and counterstained with tartrazine (0.25%) in saturated picric acid. For the collagen analysis, paraffin-embedded sections were stained using the Gordon and Sweet reticular fiber stain, which stains collagen types I and III; the sections were counterstained with eosin. These sections were then viewed using a light microscope and digital images were acquired and analyzed using ImagePro Plus (Media Invitrogen Life Technologies, CA, USA) and nuclease-free water. The thermal profile used to amplify the PCR products included an initial 2 min incubation at 95°C, followed by 50 cycles of denaturation at 95°C for 3 sec, annealing at 58/59/60°C (depending on the primers for each gene; see Table 1 ) for 20 sec and elongation at 72°C for 20 sec.
The fluorescence readings were recorded after each 72°C step. Dissociation curves were performed after each PCR run to ensure that a single PCR product had been amplified per primer set. Each sample was measured in triplicate and a control sample, containing no template, was included in each run. The mRNA levels of each gene for each animal were normalized to the 18S rRNA values for that animal, normalized using the ΔΔCt method and expressed relative to the mean gene mRNA levels in control fetuses.
Malondialdehyde assay
Malondialdehyde (MDA) levels were used as a measure of lipid peroxidation and, therefore, oxidative stress. The MDA method was based on measuring the absorbance of thiobarbituric acid (TBA)-MDA, as previously described (45 
Statistical analysis
Results are presented as the mean (SD). Body and organ weights: At necropsy, there was no difference in body weight between the control (4.1 kg (SD 0.4)) and ethanol-exposed (3.8 kg (SD 0.7)) fetuses; similarly, fetal organ weights did not differ between treatment groups. When adjusted for body weight, heart weight was greater in ethanol-exposed fetuses (8.8 g/kg (SD 1.8))
compared to control fetuses (7.2 g/kg (SD 1.3); p=0.048). There were no significant differences in the weights of the other organs when adjusted for body weight (data not shown).
Lung growth: Lung weight, both absolute and relative to fetal body weight, did not differ between control and ethanol-exposed fetuses. Similarly, lung volume at 20 cmH 2 O did not differ between control and ethanol-exposed fetuses (Table 2) .
Lung DNA concentration and total lung DNA content (both absolute and relative to fetal body weight) were similar in control and ethanol-exposed fetuses. Lung protein concentration and total lung protein content (both absolute and relative to fetal body weight) were also similar between treatment groups (Table 2) . stained positive for caspase-3, was also similar in control (9.8% (SD 8.3)) and ethanolexposed (6.5% (SD 5.2)) fetuses.
Lung parenchyma morphometry:
Tissue-space and air-space fractions were similar between treatment groups. Alveolar number, the average distance between alveolar walls (mean linear intercept) and septal thickness were also not altered by ethanol exposure ( Table 2 ). The number of type-II alveolar epithelial cells/mm 2 of tissue was not different between control (8.2 (SD 1.3)) and ethanol-exposed (7.6 (SD 1.6)) fetuses.
Lung elastin and collagen contents:
The area of lung tissue stained for elastin was not different between control (2.8% (SD 1.3)) and ethanol-exposed fetuses (2.7% (SD 1.7)).
The expression of COLIA1 was significantly greater (p=0.017) in ethanol-exposed fetuses (1.76 (SD 0.60)) compared to controls (1.00 (SD 0.69)) ( Figure 2 ). COLIA2
mRNA levels tended to be increased (p=0.066) following ethanol exposure (control: 1.00 (SD 0.63); ethanol: 1.57 (SD 0.63)); however COLIII mRNA levels after ethanol exposure (1.00 (SD 0.46)) were similar to control levels (1.00 (SD 0.66)). The percentage of collagen in the lung parenchyma was greater in ethanol-exposed fetuses 
Lung growth
Previous studies in rodents have shown that ethanol exposure during gestation causes a marked reduction in lung weight and RNA, DNA and protein contents in the fetal lung (33, 50) . In contrast, repeated ethanol exposure during late gestation in the present study did not alter fetal body weight or lung weight, lung DNA or protein contents or lung cell proliferation or apoptosis. These differences may be attributed to the timing and dose of ethanol exposure or differences between species. For example, in the present study a daily dose of ethanol was infused during a 1 h period into the maternal circulation during the last third of gestation, simulating a "binge" pattern of drinking. Each daily infusion produced a rise in PEC to a maximum of 0.12 g/dL and 0.11 g/dL in the ewe and fetus, respectively, which returned to control baseline over an 8 h period. In rodent studies, pregnant dams were either continuously exposed to high levels of ethanol via their drinking water throughout pregnancy (33) or to high levels of ethanol over a 3 day period during mid-gestation (50) . It is likely that exposure to high ethanol concentrations in early pregnancy, as in many rodent studies, reduces body and lung growth, but repeated ethanol exposure late in gestation, as in our study, does not.
Lung parenchyma morphometry
It has been suggested that prenatal ethanol exposure causes a delay in lung development (50) . However, no previous studies have investigated the effects of prenatal ethanol exposure on alveolar structure using detailed morphometric techniques.
Ours is the first study to show that repeated ethanol exposure during the period of alveolarization does not significantly alter the percentage of tissue or air space within the fetal lung, which is consistent with the lack of changes in lung growth that were observed. Prenatal ethanol exposure also does not affect alveolar number, alveolar diameter, as measured by the mean linear intercept method, or septal thickness.
Therefore, repeated daily ethanol exposure during the third-trimester equivalent does not appear to alter alveolarization. In agreement with this finding, the deposition of elastin in the fetal lung, which occurs at the tips of the secondary crests and regulates alveolar formation (20, 37) , was also not altered by ethanol exposure.
Collagen deposition
Prenatal ethanol exposure increases the expression of COLIA1 in the fetal lung and the deposition of collagen fibers types I and III, which constitute ~90% of the collagens within the lung (10). These findings are similar to studies in adults that have shown that alcohol consumption results in increased procollagen type I expression in the liver, duodenum and pancreas, resulting in fibrosis in these organs (11, 12, 46 ). An increase in collagen deposition in the lung is also associated with pulmonary fibrosis, which reduces lung distensibility, which in turn decreases forced expiratory volume and forced vital capacity (10) . Therefore, an increase in collagen expression and deposition in the fetal lung in response to prenatal ethanol exposure could be detrimental to postnatal lung function if these alterations become more marked and persist after birth.
The mechanisms by which alcohol consumption increases collagen deposition are unknown, but we speculate that they may involve an up-regulation of transforming growth factor beta 1 (TGFβ1). Previous studies have shown that acetaldehyde, the primary product of ethanol biotransformation, stimulates procollagen type I gene transcription via an increase in TGFβ1 mRNA levels (5, 11, 46) . It is well established that TGFβ1 is not only capable of inducing collagen synthesis (5, 32), but can reduce the rate of collagen degradation, resulting in an accumulation of collagen. For example, collagen is degraded by matrix metalloproteinases (MMPs), and the activity of MMPs is inhibited by matrix metalloproteinase inhibitors (TIMPs). TGFβ1 can reduce MMP expression and up-regulate TIMP production, thereby decreasing collagen degradation (5) . It also has been postulated that exposure to ethanol results in a modified crosslinked collagen that is less susceptible to collagenases (5). However, this has not been investigated in the present study and further studies are required to determine if prenatal ethanol exposure alters TGFβ1 expression and down-stream signaling events, which could result in the increase in collagen deposition that occurs within the fetal lung.
Ethanol exposure has been shown to cause oxidative stress in pancreatic stellate cells, as indicated by increased lipid peroxidation (3). This increase in oxidative stress is thought to mediate ethanol-induced stimulation of collagen synthesis, as it can be prevented by vitamin E, an anti-oxidant (3). In the present study, MDA levels tended to be increased by prenatal ethanol exposure. As MDA levels are an indication of lipid peroxidation, and therefore oxidative stress, it is possible that the increased collagen synthesis in the fetal lung in response to prenatal ethanol exposure is partly caused by the generation of free radicals during ethanol biotransformation.
Surfactant protein expression
The mRNA expression of SP-A, -B and -D in the fetal lungs was reduced to approximately one third of control levels following daily ethanol exposure. As surfactant proteins are components of surfactant, our data indicate that prenatal ethanol exposure decreases surfactant synthesis. As type-II alveolar epithelial cells synthesize and secrete surfactant, a reduction in surfactant protein expression may be due to a reduction in the number of type-II cells. Although previous studies in adults have shown that ethanol exposure can reduce surfactant synthesis and increase type-II cell apoptosis (7, 8, 28, 29) , our study has shown that prenatal ethanol exposure does not appear to affect type-II cell number. Alternatively, the reduction in SP expression that occurs in response to prenatal ethanol exposure may be due to a direct effect of ethanol on surfactant synthesis or a reduction in the number of lamellar bodies per type-II cell (lamellar bodies are organelles within type-II cells that produce and store surfactant).
The mechanisms involved in the reduction in SP expression are unknown, but may be due to oxidative stress and decreased glutathione availability (7, 8, 28, 29) .
Surfactant acts to reduce the surface tension at the air-liquid interface within the lung and this helps to prevent alveolar collapse at end-expiration. Therefore, a reduction in surfactant could increase the risk of respiratory distress syndrome (RDS) at birth in babies that have been exposed to ethanol during pregnancy, especially in those born preterm. It is of interest that chronic ethanol exposure in adults is associated with an increased risk of ARDS (41), which involves decreased surfactant production in the lungs. prenatal endotoxin exposure is associated with an increase in SP expression (42, 43) .
Therefore, we speculate that a decrease in SP expression, as observed in the present study, may be associated with an immunosuppressed state in the fetal lung.
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Lung inflammatory status
We have shown that repeated ethanol exposure during the last third of gestation reduces lung pro-inflammatory cytokine expression, particularly the expression of IL-1β and IL-8, which was reduced by ~90% compared with control levels. A reduction in pro-inflammatory cytokines in response to alcohol consumption has also been demonstrated in adults (16) and it is thought that, under these circumstances, the lungs would be less able to mount an effective immune response when exposed to pathogens (16) . Fetal ethanol exposure has also been shown to decrease macrophage number and function (24) , again indicating that ethanol exposure has a suppressive effect on the innate immune system. The long-term effects of a severe reduction in the basal level of pro-inflammatory cytokines in the lung following fetal ethanol exposure, however, remain to be determined.
Ethanol exposure is known to increase the risk of infection in both adults and neonates (22) , and previous studies have shown that maternal alcohol consumption increases the risk of early-onset sepsis in very low birthweight newborns (23) . Ethanol exposure can also increase the risk of preterm birth, and preterm infants are more susceptible to respiratory syncytial virus infections (49) . These findings indicate that prenatal ethanol exposure is associated with an increased susceptibility to infection in early postnatal life and this could be due, in part, to a reduction in basal pro-inflammatory cytokine levels.
Conclusions
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In conclusion, prenatal ethanol exposure during the third-trimester equivalent increases collagen expression and deposition and decreases SP and pro-inflammatory cytokine gene expression in the fetal lung. If these changes persist to birth, they could contribute to an increased risk of RDS in the neonate, reduced lung function post-natally, and/or an increased susceptibility to neonatal lung infection. Studies investigating the effects of fetal alcohol exposure on post-natal respiratory health outcomes in humans are required. and TNF-α (D) mRNA levels, determined by qRT-PCR, in control fetuses (saline) and fetuses exposed to ethanol. The asterisk (*) denotes data from ethanol-exposed fetuses that are significantly different (p<0.05) from control values. 
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